JW Holdings Corporation (KRX:096760)

Market Cap	217.49B
Revenue (ttm)	887.71B
Net Income (ttm)	62.62B
Shares Out	70.73M
EPS (ttm)	874.00
PE Ratio	3.52
Forward PE	n/a
Dividend	115.00 (3.74%)
Ex-Dividend Date	Dec 27, 2024

Volume	125,597
Average Volume	66,548
Open	3,065.00
Previous Close	2,990.00
Day's Range	3,050.00 - 3,130.00
52-Week Range	2,650.00 - 3,905.00
Beta	0.56
RSI	54.40
Earnings Date	Mar 20, 2025

About JW Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 136
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 096760

Financial Performance

In 2024, JW Holdings's revenue was 887.71 billion, a decrease of -4.35% compared to the previous year's 928.07 billion. Earnings were 62.62 billion, an increase of 229.11%.